Arcutis Execs to Present at TD Cowen Health Care Conference
Event summary
- Arcutis Biotherapeutics to present at TD Cowen’s 46th Annual Health Care Conference on March 2, 2026.
- Fireside chat scheduled for 1:50 p.m. ET with management participation.
- Webcast available via Arcutis’ website, replay accessible for 180 days post-event.
- Arcutis focuses on immuno-dermatology with three approved treatments in its portfolio.
The big picture
Arcutis’ participation in TD Cowen’s conference underscores its push to strengthen investor relations amid a competitive biopharmaceutical landscape. The event provides a platform to highlight its immuno-dermatology portfolio and pipeline, which are critical for sustaining growth in a sector driven by innovation and regulatory milestones.
What we're watching
- Pipeline Progress
- How Arcutis’ pipeline advancements will impact its market positioning in immuno-dermatology.
- Investor Sentiment
- Whether the conference presentation will bolster investor confidence amid competitive pressures.
- Regulatory Dynamics
- The pace at which Arcutis can secure approvals for its pipeline candidates in key markets.